Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
Código da empresaAVR
Nome da EmpresaAnteris Technologies Global Corp
Data de listagemDec 13, 2024
CEOPaterson (Wayne G)
Número de funcionários136
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 13
Endereço860 Blue Gentian Road
CidadeEAGAN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55121
Telefone16514930606
Sitehttps://anteristech.com/
Código da empresaAVR
Data de listagemDec 13, 2024
CEOPaterson (Wayne G)
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados